ARCHIVES

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

This article is from The Cancer Letter archive.

Vol. 05 No. 35 | August 31, 1979

Download PDF Visit The Full Archive

Related Articles

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

Committee Holds Up RFP For Frederick, Asks Six Month Delay

September 24, 1976

Epstein Alleges Conflict Of Interest Of Former Chairman And Sloan-Kettering Directors

May 15, 1992

Also in this 8-page issue: Rep. James Greenwood to become president of Biotechnology Industry Association.

July 30, 2004

Trapido To Lead NCI’s Epidemiology Program.

July 26, 2002

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

April 22, 1988